They were shouting decoupling and cutting trade all this time, and now that China has taken the first step, they all started panicking and getting angryGlobal alarms rise as China's critical mineral export ban takes hold
Several US automakers are considering moving some auto parts manufacturing to China to get around China’s export controls on rare earth magnets
Nah they will buy Trump coins for a private meeting with him and get carve outs and other exemptions for it.Put them on entity list Trump.
The dispute also has the potential to escalate if China decides it wants to prevent third countries to ship these minerals to the US, said Combs. "The biggest thing I'm watching personally is the US ability to import intermediate goods that contain Chinese rare earths, and these especially flow through Japan and South Korea," he said. "The US imports more of these as embodied materials than they do directly. So that's really where the real threat is."
Is CF used in ship construction at all? I imagine it's not very useful for hulls but what about the superstructure?
Next-generation battery expert Zhou Jianbin leaves US for China as nations seek tech edge
In a move that indicates a potential shift in the global race for and talent, a leading battery scientist with extensive academic and industry experience in the US has returned to a Chinese university to further his work on next-generation technologies.
Zhou Jianbin earned his PhD at the University of Science and Technology of China (USTC) in 2017 before working as a researcher at USTC and then in the United States at Pacific Northwest National Laboratory and the University of California, San Diego.
He spent 16 months at Sonocharge Energy, a battery start-up in the US private sector, before returning to China in March as a special professor at USTC.
***************************************************************************************************************
From NIH to SMART: senior biologist Lu Wei leaves US government post for China
Top Chinese researcher is the latest academic to leave after US President Donald Trump’s university funding cuts
A third responded so well that they got what seems to be an astonishing reprieve. The immunotherapy developed by Legend Biotech, a company founded in China, seems to have made their cancer disappear. And after five years, it still has not returned in those patients — a result never before seen in this disease.
The Legend immunotherapy is a type known as CAR-T. It is delivered as an infusion of the patient’s own white blood cells that have been removed and engineered to attack the cancer. The treatment has revolutionized prospects for patients with other types of blood cancer, like leukemia.
So they left China already?The Chinese company — now a U.S. company with headquarters in New Jersey — gained attention for its CAR-T eight years ago when it made extravagant claims, which were met by snickers from American researchers.